NASDAQ: NDRA
Endra Life Sciences Inc Stock Ownership - Who owns Endra Life Sciences?

Insider buying vs selling

Have Endra Life Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ubs Group Ag10% Owner2024-08-273,715$0.55
$2.05kBuy
Ubs Group Ag10% Owner2024-08-273,715$0.55
$2.05kBuy

1 of 1

NDRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NDRA insiders and whales buy or sell their stock.

NDRA Shareholders

What type of owners hold Endra Life Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Longboard Capital Advisors LLC55.73%299,237$1.32MInsider
Ubs Group Ag54.39%292,024$1.28MInsider
Alexander Y. Tokman30.33%162,857$716.57kInsider
David R. Wells19.52%104,789$461.07kInsider
Anthony Digiandomenico19.08%102,434$450.71kInsider
Francois Roger Michelon18.10%97,191$427.64kInsider
Virtu Financial LLC15.00%80,516$354.27kInstitution
Michael Harsh12.90%69,243$304.67kInsider
Lou Basenese9.14%49,068$215.90kInsider
Sanjiv Sam Gambhir7.98%42,857$188.57kInsider

1 of 3

NDRA vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NDRA11.85%88.15%Net Buying
ISPC0.60%99.40%
APDN5.79%94.21%
MYNZ28.43%0.00%
CHEK0.17%0.00%

Endra Life Sciences Stock Ownership FAQ

Who owns Endra Life Sciences?

Endra Life Sciences (NASDAQ: NDRA) is owned by 31.44% institutional shareholders, 233.82% Endra Life Sciences insiders, and 0.00% retail investors. Longboard Capital Advisors LLC is the largest individual Endra Life Sciences shareholder, owning 299,237.00 shares representing 55.73% of the company. Longboard Capital Advisors LLC's Endra Life Sciences shares are currently valued at $1.28M.

If you're new to stock investing, here's how to buy Endra Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.